Literature DB >> 16166943

Rituximab in diffuse large B-cell lymphoma.

Bertrand Coiffier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 16166943

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  4 in total

Review 1.  Novel CD20 monoclonal antibodies for lymphoma therapy.

Authors:  Shundong Cang; Nikhil Mukhi; Kemeng Wang; Delong Liu
Journal:  J Hematol Oncol       Date:  2012-10-11       Impact factor: 17.388

Review 2.  Diagnosis and treatment of CD20 negative B cell lymphomas.

Authors:  Tasleem Katchi; Delong Liu
Journal:  Biomark Res       Date:  2017-02-07

3.  Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting.

Authors:  Jiangning Zhao; Zhenshu Xu; Delong Liu; Quanyi Lu
Journal:  Cancer Cell Int       Date:  2012-08-23       Impact factor: 5.722

4.  Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma.

Authors:  Byung Woog Kang; Sang Kyun Sohn; Joon Ho Moon; Yee Soo Chae; Jong Gwang Kim; Soo Jung Lee; Won Seog Kim; Je-Jung Lee; Se Ryeon Lee; Keon Uk Park; Ho Sup Lee; Won Sik Lee; Jong-Ho Won; Moo-Rim Park; Jae-Yong Kwak; Min Kyoung Kim; Hyo Jung Kim; Sung Yong Oh; Hye Jin Kang; Cheolwon Suh
Journal:  Blood Res       Date:  2014-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.